LOTTE rental earned the highest 'AAA' rating in the MSCI ESG evaluation for two consecutive years

LOTTE rental earned the highest 'AAA' rating in the MSCI ESG evaluation for two consecutive years

Became one of the world's highest ESG leader groups The only company in the world's passenger ground transportation industry to receive the highest AAA rating for two consecutive years Highest rating in 'governance' area, which has the highest...

Brain Navi achieves U.S. FDA approval for neurosurgical robot NaoTrac

Brain Navi achieves U.S. FDA approval for neurosurgical robot NaoTrac

ZHUBEI CITY, June 17, 2025 /PRNewswire/ -- Brain Navi Biotechnology, a medical robotics company founded in 2015 in Taiwan by surgeon and serial entrepreneur Jerry Chen, has reached another major milestone. Following previous approvals from the...

SIFF opens with record-breaking premiere rate

SIFF opens with record-breaking premiere rate

SHANGHAI, June 16, 2025 /PRNewswire/ -- A news report from english.shanghai.gov.cn: In Shanghai, a movie ticket stub isn't the end of the story—it's just the beginning of your connection with the city. During the Shanghai International Film...

The MWCapital Awards recognise the international tech projects with the greatest impact on sustainability

The MWCapital Awards recognise the international tech projects with the greatest impact on sustainability

The first edition of the awards, organised by Mobile World Capital in collaboration with B Lab Spain, GSMA Foundry, the State Secretariat for Digitalisation and Artificial Intelligence (SEDIA) and Red. es, received 157 entries from 34 countries. The...

Ecomobi and Lazada Affiliate: From ground Zero to a regional force in Southeast Asia's Affiliate landscape

Ecomobi and Lazada Affiliate: From ground Zero to a regional force in Southeast Asia's Affiliate landscape

JAKARTA, Indonesia, June 12, 2025 /PRNewswire/ -- At Lazada Affiliate SEA Awards 2025, Ecomobi received "Affiliate of the Year 2024", a recognition given to top performers for their outstanding contributions to the affiliate marketing ecosystem. A...

Yew Chung College of Early Childhood Education offers Hong Kong's Only Government-Recognized Special Child Care Work Registration within its PGDE(ECE) Programme

Yew Chung College of Early Childhood Education offers Hong Kong's Only Government-Recognized Special Child Care Work Registration within its PGDE(ECE) Programme

HONG KONG, June 10, 2025 /PRNewswire/ -- Yew Chung College of Early Childhood Education (YCCECE) proudly announces that its Postgraduate Diploma in Education (Early Childhood Education)(PGDE(ECE)) Programme has received formal recognition from the...

Acer Reports May Revenues at NT$19.17 Billion, Up 3.1% Month-on-month

Acer Reports May Revenues at NT$19.17 Billion, Up 3.1% Month-on-month

TAIPEI, June 9, 2025 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for May at NT$19.17 billion with 3.1% growth month-on-month. Consolidated revenues for year-to-May reached NT$99.18 billion with 1.4% growth YoY, while...

Duke-NUS celebrates 20 years of medical innovation with largest ever graduating class

Duke-NUS celebrates 20 years of medical innovation with largest ever graduating class

Duke-NUS Medical School's Class of 2025 graduates 121 medical and doctoral students, including MDs, MD-PhDs, PhDs, and masters' degrees Landmark first batch of Masters in Patient Safety and Healthcare Quality graduates, unique to Southeast Asia...

AccurEdit Therapeutics' ART001 Becomes China's First Gene Editing Therapy to Receive FDA Regenerative Medicine Advanced Therapy (RMAT) Designation

AccurEdit Therapeutics' ART001 Becomes China's First Gene Editing Therapy to Receive FDA Regenerative Medicine Advanced Therapy (RMAT) Designation

RMAT designation expected to expedite development; 72 weeks interim clinical trial data showing sustainable reduction of TTR over 90% with no significant adverse events. SUZHOU, China, May 29, 2025 /PRNewswire/ -- AccurEdit Therapeutics today...

Kexing Biopharm's GB18 project received clearance of IND application from NMPA and FDA

Kexing Biopharm's GB18 project received clearance of IND application from NMPA and FDA

SHENZHEN, China, May 29, 2025 /PRNewswire/ -- On May 26th, Kexing Biopharm (688136.SH) announced that the National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for its independently developed...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • menu
    menu